(4aR,5aR,11aR,12aS)-8-amino-2,12,12-trihydroxy-4a,5a,6,7,11,11a,12,12a-octahydro-[1,3,2]dioxaphosphinino[4',5':5,6]pyrano[3,2-g]pteridin-10(4H)-one 2-oxide hydrobromide dihydrate

Catalog No. :
ACCQYR484
CAS No. :
2301083-34-9
Molecular Formula :
C10H19BrN5O10P
Molecular Weight :
480.17

IUPAC Name:(4aR,5aR,11aR,12aS)-8-amino-2,12,12-trihydroxy-4a,5a,6,7,11,11a,12,12a-octahydro-[1,3,2]dioxaphosphinino[4',5':5,6]pyrano[3,2-g]pteridin-10(4H)-one 2-oxide hydrobromide dihydrate

(4aR,5aR,11aR,12aS)-8-amino-2,12,12-trihydroxy-4a,5a,6,7,11,11a,12,12a-octahydro-[1,3,2]dioxaphosphinino[4',5':5,6]pyrano[3,2-g]pteridin-10(4H)-one 2-oxide hydrobromide dihydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4aR,5aR,11aR,12aS)-8-amino-2,12,12-trihydroxy-4a,5a,6,7,11,11a,12,12a-octahydro-[1,3,2]dioxaphosphinino[4',5':5,6]pyrano[3,2-g]pteridin-10(4H)-one 2-oxide hydrobromide dihydrate
IUPAC Name(4aR,5aR,11aR,12aS)-8-amino-2,12,12-trihydroxy-4a,5a,6,7,11,11a,12,12a-octahydro-[1,3,2]dioxaphosphinino[4',5':5,6]pyrano[3,2-g]pteridin-10(4H)-one 2-oxide hydrobromide dihydrate
Molecular FormulaC10H19BrN5O10P
Molecular Weight480.17
SMILESOC1([C@@]2([H])[C@@](NC3=C(C(N=C(N3)N)=O)N2)([H])O[C@@]4([H])[C@]1([H])OP(O)(OC4)=O)O.Br.O.O
InChI KeyGGLKTKQOHMCQHF-UNHNTEMGSA-N
CAS No.2301083-34-9

Synthetic Route by SureRoute

1. ACCQYR484 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCQYR484 route product structure diagram
    ACCQYR4842301083-34-9
Inquiry

2. ACCQYR484 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCQYR484 route product structure diagram
    ACCQYR4842301083-34-9
Inquiry

Comments (0)